{"effective_time":"20171114","id":"74b491e4-c79f-331b-622a-f88d7ac0fd67","openfda":{},"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL NDC 55292-302-01 100 Tablets Tranxene* T-Tab ® Tablets (clorazepate dipotassium tablets, USP) 7.5 mg CIV DISPENSE THE ENCLOSED MEDICATION GUIDE TO EACH PATIENT. GO TO www.recordatirarediseases.com Rx only RECORDATI RARE DISEASES GROUP Each tablet contains 7.5 mg clorazepate dipotassium. See package insert for full prescribing information. Store at 20-25ºC (68-77ºF). See USP controlled room temperature. Protect from moisture. Keep bottle tightly closed. Dispense in a USP tight, light-resistant container. Do not accept if seal over bottle opening is broken or missing. Manufactured by: AbbVie LTD Barceloneta, PR 00617 For: Recordati Rare Diseases Inc. Lebanon, NJ 08833, U.S.A. Exp. Lot 04-B186-R6 (4390) 7.5 mg"],"set_id":"5ffeed77-ea55-44ab-88cd-738282a34e9a","spl_product_data_elements":["Clorazepate Dipotassium T-Tab Clorazepate Dipotassium CLORAZEPATE DIPOTASSIUM CLORAZEPIC ACID SILICON DIOXIDE FD&C YELLOW NO. 6 MAGNESIUM OXIDE MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE POTASSIUM CARBONATE POTASSIUM CHLORIDE TALC ORANGE FREEFORM T;OV;32"],"spl_unclassified_section":[""],"version":"5"}